In p53 wild-type HCC cells, this activates p53; in p53-deficent Hep3B cells, it increases c-Myc acetylation to up-regulate TRAIL expression, which also leads to apoptosis (Figure 8). The gene discussed is TP53; the disease is hepatocellular carcinoma.